Start Date
September 30, 2022
Primary Completion Date
March 31, 2024
Study Completion Date
November 30, 2024
Cyclophosphamide
pre-transplant conditioning treatment
Fludarabine
pre-transplant conditioning treatment
Total Body Irradiation
pre-transplant conditioning treatment
Busulfan
pre-transplant conditioning treatment
Mesna
given with cyclophosphamide
Sirolimus
post-transplant treatment for GVHD
Mycophenolate Mofetil
post-transplant treatment for GVHD
Filgrastim
post-transplant treatment for GVHD
Cyclophosphamide
post-transplant treatment for GVHD
Bone Marrow Transplant
Transplant with investigational bone marrow product
Lead Sponsor
Center for International Blood and Marrow Transplant Research
NETWORK
Ossium Health, Inc.
INDUSTRY